자폐스펙트럼장애 치료 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has released a new comprehensive report on the global Autism Spectrum Disorder (ASD) Treatment Market, providing a thorough analysis of key market dynamics, including drivers, challenges, opportunities, and emerging trends. This report is designed to assist stakeholders in making well-informed decisions as the market grows over the coming years.

Key Insights:

• Autism Spectrum Disorder Treatment Market Size (2025E): US$ 2.1 Bn
• Projected Market Value (2032F): US$ 3.2 Bn
• Global Market Growth Rate (CAGR 2025 to 2032): 6.4%

Autism Spectrum Disorder Treatment Market - Report Scope:

The global ASD treatment market is primarily driven by an increasing awareness of the disorder, leading to earlier diagnoses and more timely interventions, which improve developmental outcomes for individuals with autism. With a rising focus on personalized medicine and continuous innovations in research, the market is expected to experience robust growth, especially with the adoption of new therapies and technological advancements in treatment delivery.

Market Drivers:

The growth of the ASD treatment market is influenced by several factors, including the increasing awareness and early diagnosis of autism, which result in timely and more effective treatments. Governments and non-governmental organizations are also investing in autism research, leading to innovations in treatment strategies. In particular, the increasing adoption of telehealth and digital therapeutics is making ASD care more accessible, especially in underserved regions. The expanding global focus on personalized medicine is also helping to create more targeted, effective treatments for individuals with autism. Furthermore, the launch of new therapies and advancements in research into drug development are expected to continue driving the market forward.

Market Restraints:

Despite these promising growth prospects, the ASD treatment market faces certain challenges. High treatment costs and limited insurance coverage for certain therapies can restrict patient access to effective care. Moreover, the lack of standardized treatment guidelines in many regions, coupled with the complexity of diagnosing autism spectrum disorders, can hinder market growth. In addition, challenges related to the long development timelines for new therapies and stringent regulatory requirements are likely to slow the pace of innovation.

Market Opportunities:

The ASD treatment market offers substantial opportunities for growth, particularly in emerging markets where awareness and access to care are still developing. The integration of innovative technologies like telehealth and digital therapeutics is expected to expand the reach of ASD care, especially in rural and underserved areas. Governments are increasingly supporting ASD research and treatment initiatives, which will further propel market growth. There is also a significant opportunity in the development of personalized therapies, which can improve treatment outcomes for individuals with autism. Additionally, partnerships between pharmaceutical companies, research organizations, and healthcare providers are likely to lead to new breakthroughs in treatment.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global autism spectrum disorder treatment market?
• Which regions are expected to lead market growth, and what are their specific drivers?
• What are the latest innovations in treatment and technological advancements shaping the market?
• How is the regulatory environment evolving, and what challenges does it pose to market growth?
• What are the emerging trends and future outlook for the global ASD treatment market?

Competitive Intelligence and Business Strategy:

Leading companies in the global ASD treatment market, including Cortica and Teijin Pharma, are expanding their research and development efforts to bring new treatment options to market. These companies are increasingly focusing on innovations such as drug therapies, telehealth solutions, and personalized care models to improve patient outcomes. Additionally, market leaders are leveraging strategic collaborations and partnerships to accelerate the development of new treatments and enhance their product offerings.

Key Companies Profiled:

• F. Hoffmann-La Roche Ltd
• Aurobindo Pharma Ltd.
• Curemark, LLC
• Yamo Pharmaceuticals
• PaxMedica
• Janssen Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd.
• H. Lundbeck A/S
• Otsuka Holdings Co. Ltd.
• AstraZeneca
• Pfizer, Inc.
• Eli Lilly and Company

Autism Spectrum Disorder Treatment Market Segmentation:

By Treatment

• Behavioral Therapy
• Drug Therapy
• Complementary and Alternative Therapies
• Others

By Indication

• Persuasive Developmental Disorder
• Autistic Disorder
• Asperger Syndrome
• Others

By End User

• Hospitals
• Specialized Autism Treatment Centers
• Outpatient Care Centers
• Homecare Settings
• Others

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Autism Spectrum Disorder Treatment Market Snapshot, 2025 and 2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
  • 2.3.3. Global Healthcare Spending Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Treatment Adoption Analysis
• 3.2. Disease Epidemiology
• 3.3. Regulatory Landscape
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Analysis

4. Global Autism Spectrum Disorder Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Bn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
• 4.3. Global Autism Spectrum Disorder Treatment Market Outlook: Treatment
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Treatment, 2019-2024
  • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
    • 4.3.3.1. Behavioral Therapy
    • 4.3.3.2. Drug Therapy
      • 4.3.3.2.1. Antipsychotic Drugs
      • 4.3.3.2.2. Stimulants
      • 4.3.3.2.3. SSRIs/Antidepressants
      • 4.3.3.2.4. Others
    • 4.3.3.3. Complementary & Alternative Therapies
    • 4.3.3.4. Others
  • 4.3.4. Market Attractiveness Analysis: Treatment
• 4.4. Global Autism Spectrum Disorder Treatment Market Outlook: Indication
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2024
  • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
    • 4.4.3.1. Persuasive Developmental Disorder
    • 4.4.3.2. Autistic Disorder
    • 4.4.3.3. Asperger Syndrome
    • 4.4.3.4. Others
  • 4.4.4. Market Attractiveness Analysis: Indication
• 4.5. Global Autism Spectrum Disorder Treatment Market Outlook: End User
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024
  • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 4.5.3.1. Hospitals
    • 4.5.3.2. Specialized Autism Treatment Centers
    • 4.5.3.3. Outpatient Care Centers
    • 4.5.3.4. Homecare Settings
    • 4.5.3.5. Others
  • 4.5.4. Market Attractiveness Analysis: End User

5. Global Autism Spectrum Disorder Treatment Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Autism Spectrum Disorder Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Treatment
  • 6.2.3. By Indication
  • 6.2.4. By End User
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
  • 6.4.1. Behavioural Therapy
  • 6.4.2. Drug Therapy
    • 6.4.2.1. Antipsychotic Drugs
    • 6.4.2.2. Stimulants
    • 6.4.2.3. SSRIs/Antidepressants
    • 6.4.2.4. Others
  • 6.4.3. Complementary & Alternative Therapies
  • 6.4.4. Others
• 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
  • 6.5.1. Persuasive Developmental Disorder
  • 6.5.2. Autistic Disorder
  • 6.5.3. Asperger Syndrome
  • 6.5.4. Others
• 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 6.6.1. Hospitals
  • 6.6.2. Specialized Autism Treatment Centers
  • 6.6.3. Outpatient Care Centers
  • 6.6.4. Homecare Settings
  • 6.6.5. Others
• 6.7. Market Attractiveness Analysis

7. Europe Autism Spectrum Disorder Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Treatment
  • 7.2.3. By Indication
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
  • 7.4.1. Behavioural Therapy
  • 7.4.2. Drug Therapy
    • 7.4.2.1. Antipsychotic Drugs
    • 7.4.2.2. Stimulants
    • 7.4.2.3. SSRIs/Antidepressants
    • 7.4.2.4. Others
  • 7.4.3. Complementary & Alternative Therapies
  • 7.4.4. Others
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
  • 7.5.1. Persuasive Developmental Disorder
  • 7.5.2. Autistic Disorder
  • 7.5.3. Asperger Syndrome
  • 7.5.4. Others
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 7.6.1. Hospitals
  • 7.6.2. Specialized Autism Treatment Centers
  • 7.6.3. Outpatient Care Centers
  • 7.6.4. Homecare Settings
  • 7.6.5. Others
• 7.7. Market Attractiveness Analysis

8. East Asia Autism Spectrum Disorder Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Treatment
  • 8.2.3. By Indication
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
  • 8.4.1. Behavioural Therapy
  • 8.4.2. Drug Therapy
    • 8.4.2.1. Antipsychotic Drugs
    • 8.4.2.2. Stimulants
    • 8.4.2.3. SSRIs/Antidepressants
    • 8.4.2.4. Others
  • 8.4.3. Complementary & Alternative Therapies
  • 8.4.4. Others
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
  • 8.5.1. Persuasive Developmental Disorder
  • 8.5.2. Autistic Disorder
  • 8.5.3. Asperger Syndrome
  • 8.5.4. Others
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 8.6.1. Hospitals
  • 8.6.2. Specialized Autism Treatment Centers
  • 8.6.3. Outpatient Care Centers
  • 8.6.4. Homecare Settings
  • 8.6.5. Others
• 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Autism Spectrum Disorder Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Treatment
  • 9.2.3. By Indication
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
  • 9.4.1. Behavioural Therapy
  • 9.4.2. Drug Therapy
    • 9.4.2.1. Antipsychotic Drugs
    • 9.4.2.2. Stimulants
    • 9.4.2.3. SSRIs/Antidepressants
    • 9.4.2.4. Others
  • 9.4.3. Complementary & Alternative Therapies
  • 9.4.4. Others
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
  • 9.5.1. Persuasive Developmental Disorder
  • 9.5.2. Autistic Disorder
  • 9.5.3. Asperger Syndrome
  • 9.5.4. Others
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 9.6.1. Hospitals
  • 9.6.2. Specialized Autism Treatment Centers
  • 9.6.3. Outpatient Care Centers
  • 9.6.4. Homecare Settings
  • 9.6.5. Others
• 9.7. Market Attractiveness Analysis

10. Latin America Autism Spectrum Disorder Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Treatment
  • 10.2.3. By Indication
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
  • 10.4.1. Behavioural Therapy
  • 10.4.2. Drug Therapy
    • 10.4.2.1. Antipsychotic Drugs
    • 10.4.2.2. Stimulants
    • 10.4.2.3. SSRIs/Antidepressants
    • 10.4.2.4. Others
  • 10.4.3. Complementary & Alternative Therapies
  • 10.4.4. Others
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
  • 10.5.1. Persuasive Developmental Disorder
  • 10.5.2. Autistic Disorder
  • 10.5.3. Asperger Syndrome
  • 10.5.4. Others
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 10.6.1. Hospitals
  • 10.6.2. Specialized Autism Treatment Centers
  • 10.6.3. Outpatient Care Centers
  • 10.6.4. Homecare Settings
  • 10.6.5. Others
• 10.7. Market Attractiveness Analysis

11. Middle East & Africa Autism Spectrum Disorder Treatment Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Treatment
  • 11.2.3. By Indication
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Treatment, 2025-2032
  • 11.4.1. Behavioural Therapy
  • 11.4.2. Drug Therapy
    • 11.4.2.1. Antipsychotic Drugs
    • 11.4.2.2. Stimulants
    • 11.4.2.3. SSRIs/Antidepressants
    • 11.4.2.4. Others
  • 11.4.3. Complementary & Alternative Therapies
  • 11.4.4. Others
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025-2032
  • 11.5.1. Persuasive Developmental Disorder
  • 11.5.2. Autistic Disorder
  • 11.5.3. Asperger Syndrome
  • 11.5.4. Others
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
  • 11.6.1. Hospitals
  • 11.6.2. Specialized Autism Treatment Centers
  • 11.6.3. Outpatient Care Centers
  • 11.6.4. Homecare Settings
  • 11.6.5. Others
• 11.7. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. F. Hoffmann-La Roche Ltd
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Aurobindo Pharma Ltd.
  • 12.3.3. Curemark, LLC
  • 12.3.4. Yamo Pharmaceuticals
  • 12.3.5. PaxMedica
  • 12.3.6. Janssen Pharmaceuticals, Inc.
  • 12.3.7. Teva Pharmaceutical Industries Ltd.
  • 12.3.8. H. Lundbeck A/S
  • 12.3.9. Otsuka Holdings Co. Ltd.
  • 12.3.10. AstraZeneca
  • 12.3.11. Pfizer, Inc.
  • 12.3.12. Eli Lilly and Company

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations